Preceptis Medical

Preceptis Medical is a private medical device company that has commercialized the Hummingbird TTS, a novel system for performing pediatric tympanostomy tube placement in an office setting. This technology addresses significant drawbacks of traditional OR-based surgery, including the risks of general anesthesia, high costs, and procedural complexity. By shifting the procedure to the clinic, Preceptis offers a compelling value proposition to patients, parents, physicians, and payers. The company is positioned in a large, established market with nearly one million procedures performed annually in the US.

The Hummingbird Tympanostomy Tube System (TTS) is an integrated medical device platform enabling in-office pediatric ear tube placement without general anesthesia. It combines visualization, myringotomy, and tube delivery in a single system for a rapid, clinic-based procedure.

Preceptis competes against the entrenched standard of care: traditional surgical tympanostomy tube placement in an operating room, supported by major medtech companies supplying tubes and instruments. It also faces potential competition from other office-based tube delivery concepts and Eustachian tube dilation devices, though the Hummingbird's specific in-office tube placement system appears unique in its current commercial form.